MIRVASO 3 mg/g, gel — 1 tube(s) polyéthylène EAA : éthylène acrylique acide aluminium avec fermeture de sécurité enfant de 30 g
Medicine package · Base de données publique des médicaments (BDPM), ANSM, HAS et Assurance Maladie · France
-
CIP13
3400928027788 -
CIP7
2802778 -
CIS
68293613 -
Registration number
EU/1/13/904
What the source publishes
- Holder
- GALDERMA, THE NETHERLANDS BRANCH (PAYS-BAS)
- Active ingredients
- BRIMONIDINE, TARTRATE DE BRIMONIDINE
- Form
- gel
- Package
- 1 tube(s) polyéthylène EAA : éthylène acrylique acide aluminium avec fermeture de sécurité enfant de 30 g
- Routes
- cutanée
- Administrative status
- authorised
- Supply regime
- liste I
- Marketing status
- Déclaration de commercialisation
- Authorised on
- 2014-02-21
- Prescription
- Prescription or restricted
Names this record is found by
- MIRVASO 3 mg/g, gel — 1 tube(s) polyéthylène EAA : éthylène acrylique acide aluminium avec fermeture de sécurité enfant de 30 g
- MIRVASO 3 mg/g, gel
- BRIMONIDINE
- TARTRATE DE BRIMONIDINE
Complete source data
{
"cis": "68293613",
"cip7": "2802778",
"form": "gel",
"name": "MIRVASO 3 mg/g, gel — 1 tube(s) polyéthylène EAA : éthylène acrylique acide aluminium avec fermeture de sécurité enfant de 30 g",
"cip13": "3400928027788",
"holder": "GALDERMA, THE NETHERLANDS BRANCH (PAYS-BAS)",
"routes": [
"cutanée"
],
"holders": [
"GALDERMA, THE NETHERLANDS BRANCH (PAYS-BAS)"
],
"currency": "EUR",
"marketed": true,
"bdmStatus": null,
"useDomain": "unknown",
"publicPrice": null,
"authorisedOn": "2014-02-21",
"compositions": [
{
"name": "BRIMONIDINE",
"nature": "FT",
"strength": "3,3 mg",
"linkageNumber": "1",
"substanceCode": "38467",
"dosageReference": "1 g de gel",
"pharmaceuticalElement": "gel"
},
{
"name": "TARTRATE DE BRIMONIDINE",
"nature": "SA",
"strength": "5 mg",
"linkageNumber": "1",
"substanceCode": "60394",
"dosageReference": "1 g de gel",
"pharmaceuticalElement": "gel"
}
],
"sourceStatus": "Présentation active",
"supplyRegime": "liste I",
"dispensingFee": null,
"medicinePrice": null,
"regionalRules": "not-collected",
"targetSpecies": [],
"specialityName": "MIRVASO 3 mg/g, gel",
"marketingStatus": "Déclaration de commercialisation",
"publicationDates": {
"CIS_bdpm": "2026-11-20",
"CIS_CIP_bdpm": "2026-11-20",
"CIS_CPD_bdpm": "2026-11-20",
"CIS_COMPO_bdpm": "2026-11-20"
},
"specialityListed": true,
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "fr.ansm.bdpm"
},
"collectiveApproval": "non",
"packageDescription": "1 tube(s) polyéthylène EAA : éthylène acrylique acide aluminium avec fermeture de sécurité enfant de 30 g",
"patientEligibility": "not-assessed",
"reimbursementRates": [],
"marketingDeclaredOn": "2016-01-11",
"targetSpeciesStatus": "not-reported",
"additionalMonitoring": false,
"administrativeStatus": "authorised",
"prescriptionCategory": "prescription-or-restricted",
"activeIngredientNames": [
"BRIMONIDINE",
"TARTRATE DE BRIMONIDINE"
],
"authorisationProcedure": "Procédure centralisée",
"prescriptionConditions": [
"liste I"
],
"reimbursementIndications": null,
"authorisationSourceStatus": "Autorisation active",
"europeanAuthorisationNumber": "EU/1/13/904",
"presentationAdministrativeStatus": "authorised"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=fr" \
--data-urlencode "sourceId=fr.ansm.bdpm" \
--data-urlencode "id=fr:ansm:packages:3400928027788"